PPD downgraded by Evercore ISI Group with a new price target

4/16/21 12:11:25 PM ET

Biotechnology: Commercial Physical & Biological Resarch

Health Care

Evercore ISI Group downgraded PPD from Outperform to In-Line and set a new price target of $47.50 from $46.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$PPD

Date	Price Target	Rating	Analyst
8/5/2021	$47.50	Neutral	Credit Suisse